Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VIVO

Meridian Bioscience (VIVO) Stock Price, News & Analysis

Meridian Bioscience logo

About Meridian Bioscience Stock (NASDAQ:VIVO)

Advanced Chart

Key Stats

Today's Range
$33.97
$33.97
50-Day Range
$33.00
$33.97
52-Week Range
$20.35
$34.38
Volume
N/A
Average Volume
973,737 shs
Market Capitalization
$1.50 billion
P/E Ratio
35.02
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Meridian Bioscience and its competitors with MarketBeat's FREE daily newsletter.

VIVO Stock News Headlines

Meridian Bioscience Inc (VIVO)
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Meridian Growth Legacy MERDX
See More Headlines

VIVO Stock Analysis - Frequently Asked Questions

Meridian Bioscience, Inc. (NASDAQ:VIVO) posted its quarterly earnings data on Friday, November, 12th. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.03. The business earned $76.20 million during the quarter, compared to the consensus estimate of $68.40 million. Meridian Bioscience had a trailing twelve-month return on equity of 16.74% and a net margin of 12.70%.

Meridian Bioscience subsidiaries include Exalenz Bioscience.

Based on aggregate information from My MarketBeat watchlists, some other companies that Meridian Bioscience investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Micron Technology (MU) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
11/12/2021
Today
7/05/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:VIVO
Employees
702
Year Founded
1977

Profitability

Trailing P/E Ratio
35.02
Forward P/E Ratio
40.93
P/E Growth
N/A
Net Income
$42.46 million
Pretax Margin
16.31%

Debt

Sales & Book Value

Annual Sales
$333.02 million
Cash Flow
$1.78 per share
Price / Cash Flow
19.13
Book Value
$8.41 per share
Price / Book
4.04

Miscellaneous

Free Float
42,996,000
Market Cap
$1.50 billion
Optionable
Optionable
Beta
0.23

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:VIVO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners